🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

45+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 45 recruiting trials for “glial-tumor

RecruitingNCT07236840

Self-administered Remote Neurological Examination Using Mobile Application in Patients With Brain Tumors

🏥 Tata Memorial Centre📍 1 site📅 Started Feb 2026View details ↗
RecruitingNCT07240662

Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse Glioma

🏥 iOMEDICO AG📍 1 site📅 Started Dec 2025View details ↗
RecruitingNCT07405372

Construction and Application of an IDH Mutation-Targeted PET/MRI Imaging Framework for Precision Diagnosis of Gliomas

👨‍⚕️ Xiao Chen, Daping Hospital, Army Medical University📍 1 site📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07110246

Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas

👨‍⚕️ Sabine Mueller, MD, PHD, University of California, San Francisco📍 4 sites📅 Started Nov 2025View details ↗
Phase 1RecruitingNCT07223034

A Study of 177Lu-PSMA-617 in People With Gliomas

👨‍⚕️ Brandon Imber, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Oct 2025View details ↗
NARecruitingNCT06397560

PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial

👨‍⚕️ Robert Press, M.D., Miami Cancer Institute at Baptist Health, Inc.📍 2 sites📅 Started Apr 2025View details ↗
Phase 1RecruitingNCT06773481

BC008-1A Injection for Recurrent CNS WHO G4 Glioma

🏥 Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.📍 1 site📅 Started Apr 2025View details ↗
EARLY_Phase 1RecruitingNCT06610682

Feasibility of CSF and Plasma ctDNA in BRAF-altered Glioma During Treatment With Plixorafenib

👨‍⚕️ Karisa Schreck, MD, Johns Hopkins University📍 1 site📅 Started Apr 2025View details ↗
Phase 2RecruitingNCT06801730

Irinotecan Liposomes Combined With Bevacizumab in the Treatment of Recurrent Glioma

👨‍⚕️ Zhifeng Tian, The Central Hospital of Lishui City📍 1 site📅 Started Jan 2025View details ↗
Phase 1RecruitingNCT05460507

Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment

👨‍⚕️ Andrew J Brenner, PhD, The Cancer Therapy and Research Center at UTHSCSA📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT06546631

Investigating Mechanistic Predictors of Interpatient Variability and Temozolomide (TMZ) Induced Haematological Toxicity for Glioma Patients

🏥 University College Cork📍 1 site📅 Started Aug 2024View details ↗
EARLY_Phase 1RecruitingNCT05553041

18F-Fluciclovine PET-MRI in High-grade Glioma

👨‍⚕️ Mariam Aboian, MD,PhD, Children's Hospital of Philadelphia📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06180434

Short Term Outcomes After PRoton and PhotoN RadiOtherapy for IDH Mutated Grade 2 and 3 Gliomas

👨‍⚕️ Alejandra Mendez Romero, MD PhD, Assitant Professor, Radiation Oncologist📍 1 site📅 Started May 2024View details ↗
Phase 3RecruitingNCT06330337

Effect of Electroacupuncture Combined With Paclitaxel Clinical Efficacy of Patients With Recurrence of High-grade Glioma

🏥 The Third Affiliated hospital of Zhejiang Chinese Medical University📍 1 site📅 Started Apr 2024View details ↗
NARecruitingNCT06381726

Personalized Rendering of Motor System Functional Plasticity Potential to Improve Glioma Resection and Quality of Life

👨‍⚕️ Lorenzo Bello, MD, University of Milan📍 1 site📅 Started Mar 2024View details ↗
RecruitingNCT06036381

Spatial and Temporal Characterization of Gliomas Using Radiomic Analysis

👨‍⚕️ Dr. ARCHYA DASGUPTA, MD, Tata Memorial Hospital📍 1 site📅 Started Feb 2024View details ↗
Phase 1, PHASE2RecruitingNCT06161519

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

👨‍⚕️ Jing Wu, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Jan 2024View details ↗
Phase 1, PHASE2RecruitingNCT06011109

Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab

👨‍⚕️ Nicole Shonka, MD, University of Nebraska📍 2 sites📅 Started Dec 2023View details ↗
RecruitingNCT06620055

Development of an Artificial Intelligence Model for Optimising Therapy in Gliomas Gliomas

👨‍⚕️ Giuseppe Toffoli, Centro di Riferimento Oncologico di Aviano (CRO) - IRCCS📍 3 sites📅 Started Nov 2023View details ↗
Phase 2RecruitingNCT05964569

Feasibility of Individualized, Model-guided Optimization of Proton Beam Treatment Planning in Patients With Low Grade Glioma

🏥 University Hospital Heidelberg📍 1 site📅 Started Nov 2023View details ↗
Page 1 of 3Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →